Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List
This article is from
The Cancer Letter
archive.
Vol. 18 No. 06 | February 7, 1992
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
HHS Reinvention May Include Privatizing Of NIH Clinical Center
May 19, 1995
TCL Archive
FDA orders “limited distribution” for lung cancer drug Iressa.
June 24, 2005
TCL Archive
Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer
December 27, 2002
TCL Archive
Clearinghouse Finds Insecticide, Hair Dye Are Carcinogens
December 1, 1978
TCL Archive
DSMB Recommends Discontinuing Phase III Perifosine Combination Trial
March 29, 2013
TCL Archive
“Whatever Happened To…?” ACS Follows Up Five Years Later
August 26, 1977